ST Segment Yükselmeli Miyokard İnfarktüsü ile Başvuran Hastalarda Hastane İçi ve Uzun Dönem Mortalitenin Değerlendirilmesi: Üçüncü Basamak Kardiyoloji Merkezi Deneyimi

Abstract

Objective Ischemic heart disease remains the leading cause of death. Not only strategies of health care providers but also population characteristics are also important to extend life expectancy in patients with cardiovascular disease. Thus clinical studies including national cohort of patients provide important insights into the real-life health care. We aimed to assess intra-hospital and long-term outcomes in patients with ST-elevation myocardial infarction (STEMI). Materials and MethodsA total of 178 STEMI patients treated with primary percutaneous coronary intervention (PCI), who were documented to be death or responded the telephone interview, were included into the analyses. These patients were divided into three groups according to age (Group-1: <35 years, Group-2: ≥35-60 years, and Group-3: ≥ 60 years). Mortality and nonfatal cardiovascular complications were compared in three groups.Results Median period of follow-up was 95 months. At the intra-hospital period, re-myocardial infarction was occurred in 4 patients while death was seen in 4. During the long term follow-up, re-myocardial infarction was occurred in 30 patients. Incidence of re-myocardial infarction did not differ among the groups. Long-term mortality among study patients was found to be 27.5 % (n=49). The mortality rates between the groups were significantly different (13.3% for group-1, 16.8% for group-2, 53.5% for group-3, respectively) (p <0.001) ConclusionIn conclusion, the present study is an evaluation of intra-hospital and long-term outcomes in patients presented with STEMI and treated with primary PCI. Over the 95 months follow-up, all cause mortality was found to be 27.5% in those.